Maria M Caffarel

10PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 19, 2026
Tumor cell Jagged-1 promotes regional lymphatic metastasis and predicts recurrence in node-positive breast cancer.

|Feb 07, 2025
Cytokine-centered strategies to boost cancer immunotherapy.

Sara Manzano, María M Caffarel

|Nov 06, 2024
Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis.

Sadra Bakhshandeh, Unai Heras, Hubert M Taïeb

|Feb 28, 2024
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER<sup>+</sup> breast cancer.

Marina Bacci, Nicla Lorito, Alfredo Smiriglia

|Nov 09, 2023
New perspectives in cancer immunotherapy: targeting IL-6 cytokine family.

Maria Florencia Soler, Andrea Abaurrea, Peio Azcoaga

|May 30, 2023
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.

Isabel Tundidor, Marta Seijo-Vila, Sandra Blasco-Benito

Pageof 2

Frequent Collaborators

2 joint publications

Angela M Araujo

2 joint publications

Andrea Abaurrea

2 joint publications

Sara Manzano

1 joint publications

Justyna A Kucia-Tran